BioCopy Revenue

Biotechnology Research • Basel, Basel, Switzerland • 21-50 Employees

BioCopy revenue & valuation

Annual revenue	$2,994,425
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$9,600,000
Total funding	$8,783,300

Key Contacts at BioCopy

José Airas

Managing Director Biocopy Analytix Gmbh

Simon Schuster

Managing Director @ Biocopy Gmbh

Matthias Wiedenfels

Ceo

Claudia Skamel

Senior Director Bd&L, Ip

Company overview

Headquarters	Lichtstrasse 35, Gebäude (Building) WSJ-210, Basel, BS 4056, CH
Phone number	+4976419377870
Websites	biocopy.com biocopy.de
NAICS	541714
Keywords	Screening, Robotics, Automation, AI, Binding Kinetics
Employees	21-50
Socials

BioCopy Email Formats

BioCopy uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@biocopy.com), used 66.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@biocopy.com	66.7%
{first initial}.{last name}	j.doe@biocopy.com	33.3%

About BioCopy

BioCopy is a Swiss-German biotech company with headquarters in Basel and a state-of-the-art R&D facility in Emmendingen, Germany. The company focuses on drastically accelerating the development of safe and effective next-generation cancer drugs to improve the chance of a cure significantly. BioCopy combines artificial intelligence with its automated end-to-end engineering platform to create biotherapeutics with unrivalled efficacy and safety that are transforming the R&D process in today's pharmaceutical industry. The BioCopy platform generates data sets of high quality and quantity currently unmatched in the industry that are essential to leverage the potential of AI. This synergy reduces the research and develop-ment time of next-generation biotherapeutics from approx. 3 years to 12 months. It will save valuable time in the fight against cancer and significantly reduce the cost of cancer therapeutics. In the long term, BioCopy will expand its efforts beyond cancer and develop biotherapeutics for immunological and neurological diseases. The company is managed by Dr Matthias Wiedenfels, a proven expert and industry insider in the pharmaceutical and biotechnology industry, not least through his time as CEO of STADA Arzneimittel AG.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

BioCopy has 15 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore BioCopy's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-07-01	9	$83,300
2025-04-20	15	$8,700,000

Funding Insights

$8,783,300

Total funding amount

$8,700,000

Most recent funding amount

Number of funding rounds

BioCopy Tech Stack

Discover the technologies and tools that power BioCopy's digital infrastructure, from frameworks to analytics platforms.

Next.js

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Webpack

Miscellaneous

Strato

Hosting

Vercel

PaaS

Priority Hints

Performance

DigitalOcean Spaces

CDN

Microsoft 365

Frequently asked questions

BioCopy is located in Basel, Basel, CH.

You can reach BioCopy at +4976419377870.

BioCopy generates an estimated annual revenue of $2,994,425. This revenue figure reflects the company's market position and business performance in its industry.

BioCopy has an estimated valuation of $9,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

BioCopy has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

BioCopy has raised a total of $8,783,300 across 2 funding rounds. This investment has helped the company grow and expand its operations.